China Innovation Index
A dedicated ranking for the fast-growing Chinese pharma market. Coming late 2025
Resources
-
Innovation
JP Morgan 2025: China in the Spotlight
The quality and innovation coming out of Chinese biotechs has significantly improved in recent years, with a shift from mostly follow-on drugs to more first-in-class and best-in-class assets.
-
Innovation
China’s pharma revolution.
China has rapidly evolved from traditional medicine and low-cost generics producer to leading originator, developing first-in-class medicines.
Download the report - coming soon
IDEA Pharma’s China Pharmaceutical Innovation Index, and their accompanying White Papers, explore the performance of individual companies in much greater detail. By accessing our White Papers, you are given an inside look into our research and findings.
- 1 Methodology and analysis
- 2 Extended profiles of the Top 10 overall companies
- 3 The full top 30 ranking
- 4 The report in full
Have an opinion?
We’d love to hear your thoughts. We are open to further discussion and encourage questions and comments about our rankings. Please give us a shout to continue the conversation, we are here to answer.
